Arrow In this section

It may not always be possible to deliver results for all patients via the pan-cancer NGS panel testing route. The GLH network will therefore also offer salvage pathways capable of delivering a “minimum content” of pertinent cancer-specific genetic data.

When to trigger the salvage pathway

  • Insufficient material
  • Low neoplastic content (10-20%)
  • Clinical urgency – to be agreed with laboratory prior to referral

Requesting a test

Please refer to our Sample Requirements section before sending any samples to us for testing.

Please use this form to request this test from us.